发现新型含的帕瑟诺利德类类似物作为潜在的抗瘤剂
Xiyan Duan1, Junqi Wang1, Xiaoguang Huo2
1School of Chemistry & Chemical Engineering, Henan University of Science and Technology, Luoyang, 471003, Henan, China.
European journal of medicinal chemistry
|January 22, 2025
概括
合成了含的新型帕氏化物衍生物,其中化合物16显示为肺癌治疗的显著潜力. 这种衍生物通过抑制STAT3信号通路,在临床前模型中证明了改善生物可用性和抑制瘤生长.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症生物学 癌症生物学
背景情况:
- 的结合增强了药物的特性,如生物活性和生物可用性.
- 合成化甲酸衍生物在合成上具有挑战性.
- 帕瑟诺利德衍生物的治疗潜力正在被探索.
研究的目的:
- 通过晚期多样化策略,合成含的新型帕氏化物衍生物.
- 评估这些衍生品的抗增殖和抗转移活性.
- 评估一个有前途的前药衍生物在肺癌治疗中的治疗潜力.
主要方法:
- 通过后期阶段多样化合成含的帕氏化物衍生物.
- 针对NCI-H820,Huh-7和PANC-1细胞系的体外抗增殖试验.
- 机制研究包括殖民地形成试验和STAT3信号通路抑制.
- 在肺异种移植模型中评估水溶性,口服生物可用性和体内瘤抑制.
主要成果:
- 衍生品1对测试的癌细胞系表现出显著的抗增殖活性 (IC50值在2.16至2.66μM之间).
- 化合物1证明了剂量依赖的殖民地形成和肺癌转移的抑制,与STAT3途径的抑制有关.
- 化合物16是化合物1的前药物,与帕瑟诺利德相比,其水溶性和口服生物可用性得到改善.
- 化合物16在无明显毒性的肺患者衍生瘤异种移植模型中显著抑制瘤生长.
结论:
- 成功合成了含的新型帕氏化物衍生物.
- 化合物16作为肺癌治疗的主要化合物具有前景,因为其改善了药理动力学特性,并在临床前模型中证明了有效性.
- 需要进一步研究16号化合物作为潜在的肺癌治疗药物.
相关概念视频
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
5.8K
Bromination and chlorination of aromatic rings by electrophilic aromatic substitution reactions are easily achieved, but fluorination and iodination are difficult to achieve. Fluorine is so reactive that its reaction with benzene is difficult to control, resulting in poor yields of monofluoroaromatic products. To address this, Selectfluor reagent is used as a fluorine source in which a fluorine atom is bonded to a positively charged nitrogen.
5.8K
ortho–para-Directing Deactivators: Halogens
5.3K
Halogens are ortho–para directors. They are more electronegative than carbon. Therefore, as ring substituents, they can withdraw electrons through the inductive effect and deactivate the aromatic ring towards electrophilic substitution. Halogens also have an electron-donating resonance effect on the ring, which influences the orientation of the incoming electrophile. If an electrophile attacks at the ortho or the para position, the halogen donates electrons and stabilizes the intermediate...
5.3K


